跳至主要内容
临床试验/NCT02565017
NCT02565017已完成不适用

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2015年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
70
试验地点
1
主要终点
Acceptability of IBM Watson Oncology

研究概览

简要总结

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best chemotherapy choices for their patients. The investigators will conduct focus groups with cancer patients who have received chemotherapy treatment at MSK in order to understand cancer patients' thoughts about IBM Watson Oncology.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • MSKCC patient 18 years or older
  • Breast, lung, or colorectal cancer MSK patient as per EMR or clinician judgment having either:
  • Chemotherapeutic adjuvant or neoadjuvant treatment with the first chemo visit occurring within the past 8 months and primary treatment (i.e., surgery), occurring within the past 6 months)at MSK
  • OR chemotherapeutic treatment for metastatic disease with the first chemo visit occurring within the past 8 months at MSK
  • OR chemotherapeutic treatment through an on-going MSK clinical trial as per clinician
  • Residing in New York metro-area

排除标准

  • Non-English speakers because we do not have the resources to conduct and translate the focus groups into other languages
  • Patients who are not or will not receive their cancer care at MSKCC.
  • Patient unwilling or unable to provide informed consent

结局指标

主要结局

Acceptability of IBM Watson Oncology

时间窗: 1 year

Data collected through the brief questionnaires (e.g.,initial impressions of IBM Watson Oncology, sociodemographics) will be entered into an SPSS data file on the secure MSK server.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验